136 related articles for article (PubMed ID: 19307790)
1. Progression of renal dysfunction in cardiac transplantation after the introduction of everolimus in the immunosuppressive regime.
Moro López JA; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Agüero J; Buendía F; Ortiz V; Salvador A
Transplantation; 2009 Feb; 87(4):538-41. PubMed ID: 19307790
[TBL] [Abstract][Full Text] [Related]
2. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function.
Garrido IP; Crespo-Leiro MG; Paniagua MJ; Muñiz J; Vázquez-Rey E; Pérez-Fernández R; García-Lara J; Cuenca-Castillo JJ; Castro-Beiras A
J Heart Lung Transplant; 2005 Sep; 24(9):1226-30. PubMed ID: 16143237
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
[TBL] [Abstract][Full Text] [Related]
4. Predictors of long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients.
González-Vilchez F; de Prada JA; Castrillo C; Canteli A; Llano MF; Martín-Durán R
J Heart Lung Transplant; 2011 May; 30(5):552-7. PubMed ID: 21212001
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction.
Gustafsson F; Ross HJ; Delgado MS; Bernabeo G; Delgado DH
J Heart Lung Transplant; 2007 Oct; 26(10):998-1003. PubMed ID: 17919619
[TBL] [Abstract][Full Text] [Related]
6. Predictors of decline in renal function after lung transplantation.
Barraclough K; Menahem SA; Bailey M; Thomson NM
J Heart Lung Transplant; 2006 Dec; 25(12):1431-5. PubMed ID: 17178337
[TBL] [Abstract][Full Text] [Related]
7. mTOR inhibitors: do they help preserve renal function?
Moro J; Almenar L; Martínez-Dolz L; Agüero J; Rueda J; Arnau MA; Izquierdo M; Cano O; Sánchez-Lázaro I; Salvador A
Transplant Proc; 2007 Sep; 39(7):2135-7. PubMed ID: 17889116
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.
Rothenburger M; Teerling E; Bruch C; Lehmkuhl H; Suwelack B; Bara C; Wichter T; Hinder F; Schmid C; Stypmann J
J Heart Lung Transplant; 2007 Mar; 26(3):250-7. PubMed ID: 17346627
[TBL] [Abstract][Full Text] [Related]
9. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
[TBL] [Abstract][Full Text] [Related]
10. The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients.
Bignelli AT; Barberato SH; Aveles P; Abensur H; Pecoits-Filho R
Blood Purif; 2007; 25(3):233-41. PubMed ID: 17377377
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease after heart transplantation.
Hamour IM; Omar F; Lyster HS; Palmer A; Banner NR
Nephrol Dial Transplant; 2009 May; 24(5):1655-62. PubMed ID: 19168463
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
Celik S; Doesch A; Erbel C; Blessing E; Ammon K; Koch A; Katus HA; Dengler TJ
Transplantation; 2008 Jul; 86(2):245-50. PubMed ID: 18645486
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine and tacrolimus: influence on cardiovascular risk factors.
Hohage H; Hillebrandt U; Welling U; Zeh M; Heck M; Gerhardt UW; Suwelack BM
Transplant Proc; 2005 Mar; 37(2):1036-8. PubMed ID: 15848615
[TBL] [Abstract][Full Text] [Related]
14. Incidence and importance of de novo diabetes mellitus after heart transplantation.
Mogollón Jiménez MV; Sobrino Márquez JM; Arizón Muñoz JM; Sánchez Brotons JA; Guisado Rasco A; Hernández Jiménez MM; Romero Rodríguez N; Borrego Domínguez JM; Ordoñez Fernández A; Lage Gallé E; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3053-5. PubMed ID: 19010191
[TBL] [Abstract][Full Text] [Related]
15. Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation.
Tsagalou EP; Anastasiou-Nana MI; Margari ZJ; Vassilopoulos D
J Heart Lung Transplant; 2007 Jun; 26(6):661-4. PubMed ID: 17543796
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypertension, diabetes, and smoking on development of renal dysfunction after heart transplantation.
Sánchez Lázaro IJ; Almenar Bonet L; Martínez-Dolz L; Moro López J; Agüero Ramón-Llín J; Cano Pérez O; Rueda Soriano J; Buendía Fuentes F; Navarro Manchón J; Raso Raso R; Salvador Sanz A
Transplant Proc; 2008 Nov; 40(9):3049-50. PubMed ID: 19010189
[TBL] [Abstract][Full Text] [Related]
17. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
[TBL] [Abstract][Full Text] [Related]
19. Tolerance profile of the proliferation signal inhibitors everolimus and sirolimus in heart transplantation.
Moro JA; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Agüero J; Salvador A
Transplant Proc; 2008 Nov; 40(9):3034-6. PubMed ID: 19010183
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects of mammalian target of rapamycin inhibitors during the postoperative period after cardiac transplantation.
Bouzas-Mosquera A; Crespo-Leiro MG; Paniagua MJ; Naya C; Grille Z; Marzoa R; Barge-Caballero E; Estévez-Cid F; Alvarez-García N; Cuenca JJ; Castro-Beiras A
Transplant Proc; 2008 Nov; 40(9):3027-30. PubMed ID: 19010181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
